How ‘Ozempic face’ is pushing Gen X, already the biggest Botox and filler consumers, to the facelift table a decade early

Gen X, already leading Botox and filler use, is increasingly opting for facelifts a decade earlier due to 'Ozempic face' caused by GLP-1 weight-loss drugs, which accelerate facial aging through volume loss and sagging. Surgeons report a 50% rise in fat-grafting procedures in 2024 linked to this trend, with Gen X patients in their 40s and 50s now seeking surgical treatments typically reserved for older age groups.